The estimated 2022 incidence of overall ATTR amyloidosis, transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), and transthyretin amyloid polyneuropathy (ATTR-PN) were 16.6, 12.7, and 3.5 cases per ...
Almost all (97%) of the patients with positive planar imaging and positive single-photon emission computed tomography findings were diagnosed with ATTR-CM. Single-photon emission computed tomography ...
ATTR-CM is a rare heart failure type caused by transthyretin protein buildup, leading to heart muscle thickening and symptoms such as shortness of breath and heart failure. Hereditary ATTR-CM is more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results